Annette Fagnant

Ms. Fagnant has served the medical device industry for more than 30 years in both regulatory affairs and clinical research capacities. She has extensive experience in strategy, development, and achieving clinical and regulatory submission approvals for a wide range of medical devices, including minimally-invasive/non-surgical therapeutic devices in the obesity and Type 2 diabetes space. Prior to consulting, Ms. Fagnant was employed by Bard/Davol for nearly ten years as a Regulatory/Clinical leader at the divisional and corporate levels. As a consultant, her clients have included Beacon Endoscopic, Bard/Davol, Boston Scientific/Guidant Corporation, AngioDynamics Inc., Covidien, and Johnson & Johnson.